Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2019, Article ID 3413969, 9 pages
https://doi.org/10.1155/2019/3413969
Research Article

Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries

1Nanjing Medical University, 101 Longmian Avenue, Jiangning District, Nanjing 211166, Jiangsu Province, China
2Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, 121 Jiangjiayuan, Nanjing 210011, Jiangsu Province, China

Correspondence should be addressed to Lin Miao; nc.ude.umjn@oaimnil

Received 3 January 2019; Revised 25 April 2019; Accepted 6 May 2019; Published 1 July 2019

Academic Editor: Pierluigi Toniutto

Copyright © 2019 Hui-shan Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bergquist and E. Von Seth, “Epidemiology of cholangiocarcinoma,” Best Practice & Research Clinical Gastroenterology, vol. 29, no. 2, pp. 221–232, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. S. K. Maithel, T. Clark Gamblin, I. Kamel, C. P. Corona-Villalobos, M. Thomas, and T. M. Pawlik, “Multidisciplinary approaches to intrahepatic cholangiocarcinoma,” Cancer, vol. 119, no. 22, pp. 3929–3942, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Zheng, L. Yang, Q. Sun et al., “A new preoperative prognostic system combining CRP and CA199 for patients with intrahepatic cholangiocarcinoma,” Clinical and Translational Gastroenterology, vol. 8, no. 10, article no. e118, 2017. View at Publisher · View at Google Scholar
  4. S. H. Loosen, C. Roderburg, K. L. Kauertz et al., “CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma,” Scientific Reports, vol. 7, no. 1, article no. 16975, 2017. View at Publisher · View at Google Scholar
  5. M. Okuno, T. Ebata, Y. Yokoyama et al., “Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma,” Journal of Gastroenterology, vol. 51, no. 2, pp. 153–161, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Kitano, Y.-I. Yamashita, K. Yamamura et al., “Effects of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios on survival in patients with extrahepatic cholangiocarcinoma,” Anticancer Reseach, vol. 37, no. 6, pp. 3229–3237, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. E. W. Beal, L. Wei, C. G. Ethun et al., “Elevated NLR in gallbladder cancer and cholangiocarcinoma – making bad cancers even worse: results from the US extrahepatic biliary malignancy consortium,” HPB, vol. 18, no. 11, pp. 950–957, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Chen, Z. Dai, D. Yin et al., “Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma,” Medicine, vol. 94, no. 13, article no. e574, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Zhang, H. Wang, Z. Ning et al., “Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma,” OncoTargets and Therapy, vol. 9, pp. 6417–6423, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Zhang, H. Wang, Z. Ning et al., “Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma,” OncoTargets and Therapy, vol. 10, pp. 1441–1449, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Li, Y. Tang, Y. Song et al., “Prognostic role of pretreatment plasma d-dimer in patients with solid tumors: a systematic review and meta-analysis,” Cellular Physiology and Biochemistry, vol. 45, no. 4, pp. 1663–1676, 2018. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Suzuki, H. Shimada, T. Nanami et al., “Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer,” Surgery Today, vol. 46, no. 12, pp. 1394–1401, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-J. Shu, H. Weng, R.-F. Bao et al., “Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study,” BMC Cancer, vol. 14, no. 1, article 566, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-L. Liu, Q. Lu, J.-W. Liang et al., “High plasma fibrinogen is correlated with poor response to trastuzumab treatment in HER2 positive breast cancer,” Medicine, vol. 94, no. 5, article no. e481, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Sun, H. Ren, C.-T. Gao et al., “Clinical and prognostic significance of coagulation assays in pancreatic cancer patients with absence of venous thromboembolism,” American Journal of Clinical Oncology, vol. 38, no. 6, pp. 550–556, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Yokoyama, T. Ebata, T. Igami, G. Sugawara, M. Ando, and M. Nagino, “Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resection,” Surgery, vol. 155, no. 3, pp. 504–511, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. C. Lee, S. Park, S. Han et al., “Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma,” Journal of Gastroenterology and Hepatology, vol. 33, no. 4, pp. 958–965, 2018. View at Publisher · View at Google Scholar
  18. M. B. Bestari and N. Agustanti, “Obstructive jaundice due to pancreatic metastasis from non-small cell lung cancer.,” Acta Medica Indonesiana (The Indonesian Journal of Internal Medicine), vol. 45, no. 3, pp. 216–219, 2013. View at Google Scholar · View at Scopus
  19. M. F. Blum, V. Y. Ma, A. M. Betbadal, R. A. Bonomo, R. R. Raju, and C. D. Packer, “Trousseau’s syndrome in cholangiocarcinoma: The risk of making the diagnosis,” Clinical Medicine & Research, vol. 14, no. 1, pp. 53–59, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. S.-H. Tasi, C.-J. Juan, M.-S. Dai, and W.-Y. Kao, “Trousseau's syndrome related to adenocarcinoma of the colon and cholangiocarcinoma,” European Journal of Neurology, vol. 11, no. 7, pp. 493–496, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. C. D. Lu, K. Wang, C. Z. Zhang et al., “Outcomes of intrahepatic cholangiocarcinoma with portal vein tumor thrombus following hepatic resection,” Journal of Gastroenterology and Hepatology, vol. 31, no. 7, pp. 1330–1335, 2016. View at Google Scholar
  22. Y. Qi and J. Fu, “Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival,” Journal of B.U.ON., vol. 22, no. 2, pp. 462–467, 2017. View at Google Scholar · View at Scopus
  23. N. Schweitzer, T. Weber, M. M. Kirstein et al., “The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis,” Journal of Cancer Research and Clinical Oncology, vol. 143, no. 7, pp. 1347–1355, 2017. View at Publisher · View at Google Scholar · View at Scopus